For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Acetaminophen | Patients will receive acetaminophen at the dose of 1 gram by mouth or by enteral feeding tube every six hours for a total of 72 hours. Acetaminophen | None | None | 2 | 21 | 0 | 21 | View |
| Placebo | Patients will receive placebo by mouth or by enteral feeding tube every six hours for 72 hours. placebo | None | None | 1 | 23 | 0 | 23 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| AST or ALT >400 U/L | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |